Introduction
- Benzodiazepines are used for numerous acute states in the emergency department, especially
- IV access is often not available for patients with agitation and alternative routes must be
- This handout will focus on the pharmacokinetics of the two most utilized benzodiazepines in the
agitation
considered; the drug of choice may change depending on the route of administration
emergency department, lorazepam and midazolam for acute agitation.
Clinical Detail
| Parameter | Lorazepam IV | Lorazepam IM | Midazolam IV | Midazolam IM | Midazolam IN |
|---|---|---|---|---|---|
| Dose | Sedation: 0.5-2 mg | Sedation: 0.5-2 mg | Sedation: 0.5-2 mg | Sedation: 2.5-5 mg | Sedation: 0.1 mg/kg |
| Onset | 2-10 min (longer for anticonvulsant) | 20-30 min | 3-5 min | 5-15 min | 10 min |
| Duration | 3 – 6 hours for seizures, up to 8 hours for sedation | 6 – 8 hours | < 2 hour | 1-2 hour | 20-30 min |
| Bioavailability | 100% | 83-100% | 100% | 90% | 44% |
| Concentrations available | 2 mg/mL | 2 mg/mL | 1 mg/mL, 5 mg/mL | 1 mg/mL, 5 mg/mL | 5 mg/mL |
Evidence
| Author, year | Design / sample size | Intervention & Comparison | Outcome |
|---|---|---|---|
| Klein 2018 | Prospective observational study, N=737 | IM haloperidol 5 mg; IM ziprasidone 20 mg; IM olanzapine 10 mg; IM midazolam 5 mg; IM haloperidol 10 mg | At 15 minutes, midazolam resulted in a greater proportion of patients adequately sedated (Altered Mental Status Scale <1) compared with all other drugs |
| Martel 2005 | Prospective, double-blind, randomized, N=201 | IM droperidol 5 mg; IM midazolam 5 mg; IM ziprasidone 20 mg | Adequate sedation was achieved at 15 minutes in patients receiving midazolam compared to 30 minutes for droperidol and ziprasidone. There was no difference in respiratory depression that clinically required treatment with supplemental oxygen |
| Nobay 2004 | Prospective, double-blind, randomized, N=95 | IM midazolam; IM haloperidol; IM lorazepam | Mean time to sedation (min) — Lorazepam: 32.3 (±20); Midazolam: 18.3 (±14); Haloperidol: 28.3 (±25). Lorazepam dropped from study due to significantly longer time to sedation and awakening |
| Meehan 2001 | Prospective, double-blind, randomized, N=201 | IM olanzapine 10 mg; IM lorazepam 2 mg; Placebo | At 2 hours, olanzapine significantly greater reduction in scores on all agitation scales compared with patients treated with either placebo or lorazepam |
| Battaglia 1997 | Prospective, double-blind, randomized, N=98 | IM haloperidol 5 mg; IM lorazepam 2 mg; IM haloperidol + lorazepam | Patients who received combination treatment showed significantly greater reduction in symptoms compared to those receiving lorazepam. No significant difference from haloperidol group |
| Wyant 1990 | Observational, N=15 | IM midazolam 5 mg; IM haloperidol 10 mg; IM sodium amytal 250 mg | Midazolam was significantly more effective than haloperidol in controlling motor agitation |
Conclusions
- Midazolam has a quick onset, reliable IM absorption, and evidence that supports its use an
effective pharmacologic agent for acute agitation which could lead clinicians to argue
that midazolam is more efficacious than lorazepam for acute agitation.
References
Lorazepam. Micromedex [Electronic version].Greenwood Village, CO: Truven Health Analytics. Accessed 2020, February 24.
http://www.micromedexsolutions.com/
Midazolam. Micromedex [Electronic version].Greenwood Village, CO: Truven Health Analytics. Accessed 2020, February 24.
http://www.micromedexsolutions.com/
Nobay, et al. Acad Emerg Med. 2004;11(7):744-49.
Wyant M, et al. Psychopharmacol Bull 1990; 26:126 -9.
Meehan K, et al.. J Clin Psychopharmacol. 2001;21(4):389-397.
Battaglia J, et al. Am J Emerg Med. 1997;15(4):335-340.
Knott JC, et al. Ann Emerg Med. 2006;47(1):61-67.
Martel M, et al. Acad Emerg Med. 2006 Feb;13(2):233].
Klein LR, et al. Ann Emerg Med. 2018;72(4):374-385.
A short weekly clinical Pearl for acute care pharmacists.
Get the Friday Pearl email
Get a short weekly clinical Pearl for acute care pharmacists. No spam.
Free forever. Unsubscribe anytime. No spam.